NSJ Bioreagents

SKU(재고 관리 코드):V5850-20UG

p27 Antibody / p27Kip1, 20ug

p27 Antibody / p27Kip1, 20ug

가격·납기 및 기술자료를 확인해 드립니다.

제품 규격과 수량을 선택한 후 견적을 요청해 주세요. 대체품 검토와 SDS·COA·데이터시트 요청도 함께 접수할 수 있습니다.

이 제품 견적 요청

대표번호 070-8028-3500 · info@rndmate.com

MULTI-BRAND QUOTE
여러 제품을 함께 찾고 계신가요?
제조사가 달라도 괜찮습니다. 필요한 연구시약을 한 번에 견적받아보세요.
통합 견적 요청
Size

CDKN1B antibody targets Cyclin-dependent kinase inhibitor 1B, also called p27, KIP1 and p27Kip1, a key cell cycle regulatory protein encoded by the CDKN1B gene. Cyclin-dependent kinase inhibitor 1B is commonly known as p27 Kip1 and functions as a negative regulator of cyclin-CDK complexes, particularly those controlling the G1 to S phase transition. CDKN1B is predominantly localized to the nucleus, where it regulates cell cycle progression by inhibiting cyclin E-CDK2 and cyclin A-CDK2 activity.<br><br>As a member of the CIP/KIP family of cyclin-dependent kinase inhibitors, Cyclin-dependent kinase inhibitor 1B plays a critical role in maintaining cell cycle checkpoints and controlling cellular proliferation. CDKN1B antibody, also referred to as p27 Kip1 antibody in the literature, is widely used to study mechanisms of cell cycle arrest, differentiation, and quiescence. In addition to its nuclear functions, p27 Kip1 has been reported to exhibit cytoplasmic localization under certain biological conditions, where it may participate in cytoskeletal regulation and cell motility.<br><br>Expression of CDKN1B is tightly regulated at multiple levels, including transcription, phosphorylation, ubiquitin-mediated degradation, and subcellular localization. CDKN1B antibody is therefore useful for examining regulatory pathways that influence protein stability and intracellular distribution. Altered expression or mislocalization of Cyclin-dependent kinase inhibitor 1B has been associated with dysregulated cell proliferation and loss of growth control in disease-related research contexts.<br><br>In cancer biology, CDKN1B is frequently investigated as a tumor suppressor protein. Reduced nuclear expression of p27 Kip1 has been correlated with increased proliferative activity and adverse clinical features in multiple tumor types. CDKN1B antibody is commonly applied in studies focused on tumor classification, cell cycle dysregulation, and therapeutic response mechanisms.<br><br>This CDKN1B antibody, clone r1B4, is designed to recognize Cyclin-dependent kinase inhibitor 1B in research applications. Clone r1B4 supports detection of CDKN1B/p27Kip1 expression and localization and is suitable for studies examining cell cycle regulation, proliferation control, and CDK inhibitor signaling pathways.

Specifications

Catalog No V5850-20UG
Family Primary antibody
Qty 20ug
Formulation 0.2 mg/ml in 1X PBS with 0.05% BSA, 0.05% sodium azide
Format Purified
Clone r1B4
Host Animal Mouse
Clonality Recombinant Mouse Monoclonal
Isotype Mouse IgG2a, kappa
Species Reactivity Human
Application IHC, WB
Application Details Immunohistochemistry (FFPE): 1-2ug/ml, Western Blot: 2-4ug/ml
Application Note 1. Optimal dilution of the CDKN1B/Cyclin-dependent kinase inhibitor 1B antibody should be determined by the researcher. <br><br>2. This CDKN1B/Cyclin-dependent kinase inhibitor 1B antibody is recombinantly produced by expression in CHO cells.
Status Available
PDF Link Product Data Sheet (PDF)
Limitation This CDKN1B/Cyclin-dependent kinase inhibitor 1B antibody is available for research use only.
Uniprot # P46527
Immunogen Prokaryotic recombinant antigen corresponding to the full length p27 molecule was used as the immunogen for the CDKN1B/Cyclin-dependent kinase inhibitor 1B antibody.
Storage CDKN1B/Cyclin-dependent kinase inhibitor 1B antibody with sodium azide - store at 2 to 8oC; antibody without sodium azide - store at -20 to -80oC.
Localization Endosome, Nucleus
Title p27 Antibody / p27Kip1
전체 세부 정보 보기